Dermata Therapeutics, Inc.
DRMA
$1.29
$0.1210.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.85M | -1.86M | -1.69M | -1.70M | -2.30M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.30K | 29.50K | 37.80K | 39.20K | 37.20K |
| Change in Net Operating Assets | -675.30K | 503.20K | -149.70K | -1.03M | 332.30K |
| Cash from Operations | -2.48M | -1.33M | -1.80M | -2.69M | -1.93M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.99M | 4.19M | -- | -- | 8.54M |
| Repurchase of Common Stock | -- | 0.00 | -13.00K | -547.90K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -91.40K | 0.00 | 0.00 | 0.00 | -50.50K |
| Cash from Financing | 1.90M | 4.19M | -13.00K | -547.90K | 8.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -576.70K | 2.86M | -1.82M | -3.24M | 6.56M |